Protocolo de Actuación en Mieloma múltiple - Sociedad Asturiana ...
Protocolo de Actuación en Mieloma múltiple - Sociedad Asturiana ...
Protocolo de Actuación en Mieloma múltiple - Sociedad Asturiana ...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
BIBLIOGRAFÍA<br />
1. Dimopoulos M, Kyle R, Fermand JP, Rajkumar SV, San Miguel J, Chanan-Khan A;<br />
International Myeloma Workshop Cons<strong>en</strong>sus Panel 3. Cons<strong>en</strong>sus recomm<strong>en</strong>dations for<br />
standard investigative workup: report of the Internacional Myeloma Workshop Cons<strong>en</strong>sus<br />
Panel 3. Blood. 2011 May 5;117(18):4701-5.<br />
2. Rajkumar SV, Harousseau JL, Durie B, An<strong>de</strong>rson KC, Dimopoulos M, Kyle R,; International<br />
Myeloma Workshop Cons<strong>en</strong>sus Panel 1. Cons<strong>en</strong>sus recomm<strong>en</strong>dations for the uniform<br />
reporting of clinical trials: report of the International Myeloma Workshop Cons<strong>en</strong>sus Panel 1.<br />
Blood. 2011 May 5;117(18):4691-5.<br />
3. Durie BG, Harousseau JL, Miguel JS, Bladé J, Barlogie B, An<strong>de</strong>rson; International Myeloma<br />
Working Group. International uniform esponse criteria for multiple myeloma. Leukemia. 2006<br />
Sep;20(9):1467-73.<br />
4. The International Myeloma Working Group. Criteria for the classification of monoclonal<br />
gammopaties, multiple myeloma and related disor<strong>de</strong>rs: a report of the International Myeloma<br />
Working Group. Br. J. of Haemat 2003;121:749-757.<br />
5. Greipp PR, San Miguel J, Durie BG, Crowley JJ, Barlogie B, Bladé Internacional staging<br />
system for multiple myeloma. J Clin Oncol. 2005 May 20;23(15):3412-20.<br />
6. Paiva B, Vidriales MB, Cerveró J et al. Multiparameter flow cytometric remission is the most<br />
relevant prognostic factor for multiple myeloma pati<strong>en</strong>ts who un<strong>de</strong>rgo autologous stem cell<br />
transplantation Blood 2008;112:4017-4023.<br />
7. Paiva B, Martinez-Lopez J, Vidriales MB; Comparison of Immunofixation, Serum Free Light<br />
Chain, and Immunoph<strong>en</strong>otyping for Response Evaluation and Prognostication in Multiple<br />
Myeloma. J Clin Oncol 2011;29(12):1627-33.<br />
8. Paiva B, Gutiérrez NC, Rosiñol L, et al; PetHEMA/GEM (Programa para el Estudio <strong>de</strong> la<br />
Terapéutica <strong>en</strong> Hemopatías malignas/Grupo Español <strong>de</strong> <strong>Mieloma</strong>) Cooperative Study Groups.<br />
High-risk cytog<strong>en</strong>etics and persist<strong>en</strong>t minimal residual disease by multiparameter flor<br />
cytometry predict unsustained complete response after autologous stem cell transplantation in<br />
multiple myeloma. Blood. 2012;119(3):687-91.<br />
9. Rawstron AC, Orfao A, Beksac M et al. on behalf of the European Myeloma Network. Report<br />
of the European Myeloma Network on multiparametric flow cytometry in multiple myeloma<br />
and related disor<strong>de</strong>rs. Haematologica 2008 Mar; 93(3):431- 438.<br />
Grupo Asturiano <strong>de</strong> Linfoma y <strong>Mieloma</strong><br />
15